Table 2.
NSCLC | ||
---|---|---|
Appearance | Solid/nonsolid | 145/47 |
| ||
T stage | T1a (n=5), T1b (n=47), T1c (n=56), T2a (n=31), T2b (n=23), T3 (n=22), T4 (n=8) | |
| ||
Histology | Adenocarcinoma, 160/192 | |
Poorly differentiated carcinoma, 5/192 | ||
Squamous carcinomas, 27/192 | ||
| ||
PD-L1 expression | Adequate immunostainings, 180/192 | |
TPS | <1% in 64%, | |
>1% and <50% in 12% | ||
>50% in 24% |
PD-L1, programmed death–ligand 1; TPS, tumor proportion score.